Logo image of GL9.I

GLANBIA PLC (GL9.I) Stock Fundamental Analysis

DUB:GL9 - IE0000669501 - Common Stock

14.5 EUR
-0.01 (-0.07%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to GL9. GL9 was compared to 57 industry peers in the Food Products industry. GL9 has an average financial health and profitability rating. GL9 has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

GL9 had positive earnings in the past year.
In the past year GL9 had a positive cash flow from operations.
In the past 5 years GL9 has always been profitable.
Each year in the past 5 years GL9 had a positive operating cash flow.
GL9.I Yearly Net Income VS EBIT VS OCF VS FCFGL9.I Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

GL9 has a Return On Assets of 3.10%. This is comparable to the rest of the industry: GL9 outperforms 50.88% of its industry peers.
The Return On Equity of GL9 (5.89%) is comparable to the rest of the industry.
GL9's Return On Invested Capital of 9.81% is amongst the best of the industry. GL9 outperforms 85.96% of its industry peers.
The Average Return On Invested Capital over the past 3 years for GL9 is above the industry average of 7.09%.
The last Return On Invested Capital (9.81%) for GL9 is above the 3 year average (9.21%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.1%
ROE 5.89%
ROIC 9.81%
ROA(3y)6.64%
ROA(5y)5.89%
ROE(3y)12.59%
ROE(5y)11.36%
ROIC(3y)9.21%
ROIC(5y)7.85%
GL9.I Yearly ROA, ROE, ROICGL9.I Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

GL9 has a Profit Margin (3.06%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of GL9 has declined.
With a decent Operating Margin value of 9.38%, GL9 is doing good in the industry, outperforming 63.16% of the companies in the same industry.
GL9's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 27.51%, GL9 is not doing good in the industry: 75.44% of the companies in the same industry are doing better.
GL9's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.38%
PM (TTM) 3.06%
GM 27.51%
OM growth 3Y27.68%
OM growth 5Y13.06%
PM growth 3Y2.53%
PM growth 5Y-1.6%
GM growth 3Y15.03%
GM growth 5Y8.57%
GL9.I Yearly Profit, Operating, Gross MarginsGL9.I Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), GL9 is creating some value.
Compared to 1 year ago, GL9 has less shares outstanding
Compared to 5 years ago, GL9 has less shares outstanding
GL9 has a worse debt/assets ratio than last year.
GL9.I Yearly Shares OutstandingGL9.I Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
GL9.I Yearly Total Debt VS Total AssetsGL9.I Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

GL9 has an Altman-Z score of 3.58. This indicates that GL9 is financially healthy and has little risk of bankruptcy at the moment.
GL9 has a better Altman-Z score (3.58) than 85.96% of its industry peers.
GL9 has a debt to FCF ratio of 3.82. This is a good value and a sign of high solvency as GL9 would need 3.82 years to pay back of all of its debts.
GL9 has a Debt to FCF ratio of 3.82. This is in the better half of the industry: GL9 outperforms 73.68% of its industry peers.
GL9 has a Debt/Equity ratio of 0.50. This is a healthy value indicating a solid balance between debt and equity.
GL9 has a Debt to Equity ratio of 0.50. This is comparable to the rest of the industry: GL9 outperforms 56.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 3.82
Altman-Z 3.58
ROIC/WACC1.48
WACC6.64%
GL9.I Yearly LT Debt VS Equity VS FCFGL9.I Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

GL9 has a Current Ratio of 1.67. This is a normal value and indicates that GL9 is financially healthy and should not expect problems in meeting its short term obligations.
GL9's Current ratio of 1.67 is fine compared to the rest of the industry. GL9 outperforms 66.67% of its industry peers.
GL9 has a Quick Ratio of 1.67. This is a bad value and indicates that GL9 is not financially healthy enough and could expect problems in meeting its short term obligations.
GL9 has a Quick ratio (0.89) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 0.89
GL9.I Yearly Current Assets VS Current LiabilitesGL9.I Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

The earnings per share for GL9 have decreased strongly by -58.14% in the last year.
GL9 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.73% yearly.
Looking at the last year, GL9 shows a very negative growth in Revenue. The Revenue has decreased by -11.61% in the last year.
The Revenue has been decreasing by -0.19% on average over the past years.
EPS 1Y (TTM)-58.14%
EPS 3Y-0.29%
EPS 5Y9.73%
EPS Q2Q%-7.35%
Revenue 1Y (TTM)-11.61%
Revenue growth 3Y-6.04%
Revenue growth 5Y-0.19%
Sales Q2Q%6.12%

3.2 Future

Based on estimates for the next years, GL9 will show a small growth in Earnings Per Share. The EPS will grow by 3.22% on average per year.
The Revenue is expected to grow by 10.90% on average over the next years. This is quite good.
EPS Next Y-6.03%
EPS Next 2Y1.36%
EPS Next 3Y3.62%
EPS Next 5Y3.22%
Revenue Next Year1.96%
Revenue Next 2Y2.59%
Revenue Next 3Y2.92%
Revenue Next 5Y10.9%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GL9.I Yearly Revenue VS EstimatesGL9.I Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B 5B
GL9.I Yearly EPS VS EstimatesGL9.I Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.50, which indicates a correct valuation of GL9.
Based on the Price/Earnings ratio, GL9 is valued a bit cheaper than the industry average as 68.42% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.06. GL9 is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 11.74, which indicates a very decent valuation of GL9.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GL9 indicates a somewhat cheap valuation: GL9 is cheaper than 68.42% of the companies listed in the same industry.
GL9's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.69.
Industry RankSector Rank
PE 12.5
Fwd PE 11.74
GL9.I Price Earnings VS Forward Price EarningsGL9.I Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

GL9's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of GL9 is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 15.69
EV/EBITDA 9.16
GL9.I Per share dataGL9.I EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The decent profitability rating of GL9 may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.28
EPS Next 2Y1.36%
EPS Next 3Y3.62%

3

5. Dividend

5.1 Amount

GL9 has a Yearly Dividend Yield of 2.18%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.27, GL9 has a dividend in line with its industry peers.
GL9's Dividend Yield is comparable with the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 2.18%

5.2 History

On average, the dividend of GL9 grows each year by 33.32%, which is quite nice.
Dividend Growth(5Y)33.32%
Div Incr Years6
Div Non Decr Years6
GL9.I Yearly Dividends per shareGL9.I Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

GL9 pays out 92.88% of its income as dividend. This is not a sustainable payout ratio.
GL9's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP92.88%
EPS Next 2Y1.36%
EPS Next 3Y3.62%
GL9.I Yearly Income VS Free CF VS DividendGL9.I Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
GL9.I Dividend Payout.GL9.I Dividend Payout, showing the Payout Ratio.GL9.I Dividend Payout.PayoutRetained Earnings

GLANBIA PLC

DUB:GL9 (9/5/2025, 7:00:00 PM)

14.5

-0.01 (-0.07%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)02-24 2026-02-24
Inst Owners22.32%
Inst Owner ChangeN/A
Ins Owners0.68%
Ins Owner ChangeN/A
Market Cap3.65B
Analysts80
Price Target16.95 (16.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.18%
Yearly Dividend0.31
Dividend Growth(5Y)33.32%
DP92.88%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.85%
PT rev (3m)5.71%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)3.09%
EPS NY rev (3m)3.09%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.46%
Revenue NY rev (3m)0.79%
Valuation
Industry RankSector Rank
PE 12.5
Fwd PE 11.74
P/S 1.08
P/FCF 15.69
P/OCF 11.79
P/B 2.08
P/tB 9.68
EV/EBITDA 9.16
EPS(TTM)1.16
EY8%
EPS(NY)1.23
Fwd EY8.52%
FCF(TTM)0.92
FCFY6.37%
OCF(TTM)1.23
OCFY8.49%
SpS13.46
BVpS6.98
TBVpS1.5
PEG (NY)N/A
PEG (5Y)1.28
Profitability
Industry RankSector Rank
ROA 3.1%
ROE 5.89%
ROCE 12.36%
ROIC 9.81%
ROICexc 10.74%
ROICexgc 24.2%
OM 9.38%
PM (TTM) 3.06%
GM 27.51%
FCFM 6.86%
ROA(3y)6.64%
ROA(5y)5.89%
ROE(3y)12.59%
ROE(5y)11.36%
ROIC(3y)9.21%
ROIC(5y)7.85%
ROICexc(3y)10.65%
ROICexc(5y)8.91%
ROICexgc(3y)25.6%
ROICexgc(5y)20.78%
ROCE(3y)11.85%
ROCE(5y)10%
ROICexcg growth 3Y28.93%
ROICexcg growth 5Y4.14%
ROICexc growth 3Y21.85%
ROICexc growth 5Y8.02%
OM growth 3Y27.68%
OM growth 5Y13.06%
PM growth 3Y2.53%
PM growth 5Y-1.6%
GM growth 3Y15.03%
GM growth 5Y8.57%
F-Score6
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 3.82
Debt/EBITDA 1.92
Cap/Depr 56.68%
Cap/Sales 2.28%
Interest Coverage 11.4
Cash Conversion 68.24%
Profit Quality 224.5%
Current Ratio 1.67
Quick Ratio 0.89
Altman-Z 3.58
F-Score6
WACC6.64%
ROIC/WACC1.48
Cap/Depr(3y)51.28%
Cap/Depr(5y)53.27%
Cap/Sales(3y)1.62%
Cap/Sales(5y)1.68%
Profit Quality(3y)136.16%
Profit Quality(5y)132.67%
High Growth Momentum
Growth
EPS 1Y (TTM)-58.14%
EPS 3Y-0.29%
EPS 5Y9.73%
EPS Q2Q%-7.35%
EPS Next Y-6.03%
EPS Next 2Y1.36%
EPS Next 3Y3.62%
EPS Next 5Y3.22%
Revenue 1Y (TTM)-11.61%
Revenue growth 3Y-6.04%
Revenue growth 5Y-0.19%
Sales Q2Q%6.12%
Revenue Next Year1.96%
Revenue Next 2Y2.59%
Revenue Next 3Y2.92%
Revenue Next 5Y10.9%
EBIT growth 1Y-0.4%
EBIT growth 3Y19.97%
EBIT growth 5Y12.85%
EBIT Next Year23.49%
EBIT Next 3Y11.63%
EBIT Next 5Y9.82%
FCF growth 1Y-12.01%
FCF growth 3Y21.96%
FCF growth 5Y21.96%
OCF growth 1Y-6.33%
OCF growth 3Y16.3%
OCF growth 5Y16.3%